Peball, Marina <br/><br/>
Nabilone for non-motor symptoms of Parkinson's disease: a randomized placebo-controlled, double-blind, parallel-group, enriched enrolment randomized withdrawal study (The NMS-Nab Study).  [electronic resource] 

 -  Journal of neural transmission (Vienna, Austria : 1996)  08 2019 
 - 1061-1072 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1435-1463 
<br/><br/><label>Standard No.: </label>10.1007/s00702-019-02021-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antiparkinson Agents--therapeutic use<br/>Cannabinoid Receptor Agonists--therapeutic use<br/>Clinical Trial Protocols as Topic<br/>Double-Blind Method<br/>Dronabinol--analogs & derivatives<br/>Female<br/>Humans<br/>Male<br/>Parkinson Disease--drug therapy<br/>Patient Selection<br/>Proof of Concept Study<br/>Treatment Outcome